The Street’s Key Stock Analysts Research Reports

$ALNY, $BKR, $HAL, $JNJ, $KLAC, $SLB, $ZBRA

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers.

Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of stocks analysts have singled out to look at carefully Thursday, as follows:

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) was started with an Outperform rating and a 128 target price at Oppenheimer.

Baker Hughes Co. (NYSE:BKR) was started with a Buy rating and a 32 target price at Deutsche Bank.

Halliburton Co. (NYSE:HAL) was started with a Buy rating and a 26 target price at Deutsche Bank.

Johnson & Johnson (NYSE:JNJ) was started with an Overweight rating and a 160 target price at Cantor Fitz.

KLA Corp. (NASDAQ:KLAC) was started with a Buy rating and a 215 target price at Nomura/Instinet.

Schlumberger Ltd. (NYSE:SLB) was started with a Buy rating and a 42 target price at Deutsche Bank.

Zebra Technologies Corp. (NASDAQ:ZBRA) was reiterated as Outperform and the 245 target price was raised to 265 at Imperial Capital.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH